Scott Clayton

Scott is an associate editor at TSI Network. He is the lead reporter and analyst for Dividend Advisor, Power Growth Investor and Canadian Wealth Advisor and a member of the Investment Planning Committee. Scott began his investment and financial career working with Pat McKeough at The Investment Reporter in the 1980s. Subsequently, he worked at the Financial Post Corporation Service for 10 years. He joined TSI Network in 1998. He is a Bachelor of Economics graduate of York University, and he also has an M.B.A. from the Schulich School of Business.

Posts by the author
Brookfield Renewable Partners reported 12.1% higher revenue and 7.6% higher cash flow in its most recent quarter while yielding a high 5.1%.
Thermo Fisher Scientific has been navigating the post-pandemic market with strategic finesse with a 1.6% earnings increase despite a 3.4% dip in revenue.
Unlocking superior returns with small-cap stocks involves navigating the high-risk, high-reward landscape.
iShares MSCI Canada Index Fund isn’t recommended because we found a better ETF that offers the same benefits at just a fraction of the fee.
Before You Invest in France, Explore France’s Economic Landscape, Government Reforms, and the Resurgence of its Thriving Tourism Industry
Newmont has boosted its production after the Newcrest Mining acquisition while buying back shares and cutting costs to improve its long-term prospects.
The iShares MSCI Germany Fund & Australia ETF together provide a gateway to Germany’s industrial strength as well as Australia’s commodity-driven economy
For Canadian investors wondering how to buy international stocks, ADRs, and international ETFs may be a safer option.
ResMed is making significant strides in the growing market for sleep apnea medical devices with a 12.5% revenue gain and 13.3% earnings gain.